Imperagen raises $6.7M Seed (United Kingdom, May 2026)
Reach the investors backing rounds like this
Backed by PXN Ventures, IQ Capital +1 more · verified emails and LinkedIn on Datapile
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering - TechCrunch
Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering TechCrunch
| Oct 09, 2026 | Sava | $36.0M | Series B | United Kingdom |
| Oct 09, 2026 | Sava Technologies | $36.0M | Series B | United Kingdom |
| Oct 08, 2026 | IMMIX | $3.5M | — | United Kingdom |
| Oct 03, 2026 | Extend Robotics | $3.3M | Seed | United Kingdom |
14,763 investors back startups in United Kingdom
You just read who funded Imperagen. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.